Skip to main content
. Author manuscript; available in PMC: 2012 Sep 1.
Published in final edited form as: Cancer Chemother Pharmacol. 2010 Nov 30;68(3):593–601. doi: 10.1007/s00280-010-1525-4

Table 1.

Experimental design

Group number Number of rats Test article Route of administration Number of daily doses Dose (mg/kg/day)
1 12 Resveratrol Intravenous 1 10
2 12 Pterostilbene Intravenous 1 11.2
3 12 Resveratrol Oral 1 50
4 12 Pterostilbene Oral 1 56
5 12 Resveratrol Oral 14 50
6 12 Pterostilbene Oral 14 56
7 12 Resveratrol Oral 1 150
8 12 Pterostilbene Oral 1 168
9 12 Resveratrol Oral 14 150
10 12 Pterostilbene Oral 14 168